Merrill A Mcpeak is Director of IOVANCE BIOTHERAPEUTICS, INC.. Currently has a direct ownership of 320,150 shares of IOVA, which is worth approximately $2.61 Million. The most recent transaction as insider was on Feb 20, 2024, when has been sold 250,000 shares (Common Stock) at a price of $9.15 per share, resulting in proceeds of $2,287,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 320K
0% 3M change
356.38% 12M change
Total Value Held $2.61 Million

MERRILL A MCPEAK Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 20 2024
BUY
Open market or private purchase
$2,287,500 $9.15 p/Share
250,000 Added 43.85%
320,150 Common Stock
Dec 21 2022
BUY
Open market or private purchase
$61,500 $6.15 p/Share
10,000 Added 12.48%
70,150 Common Stock
Aug 23 2022
BUY
Exercise of conversion of derivative security
$226,000 $5.65 p/Share
40,000 Added 39.94%
60,150 Common Stock
May 31 2022
BUY
Open market or private purchase
$68,400 $6.84 p/Share
10,000 Added 33.17%
20,150 Common Stock

Also insider at

RSSS
Research Solutions, Inc. Technology
MAM

Merrill A Mcpeak

Director

Track Institutional and Insider Activities on IOVA

Follow IOVANCE BIOTHERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IOVA shares.

Notify only if

Insider Trading

Get notified when an Iovance Biotherapeutics, Inc. insider buys or sells IOVA shares.

Notify only if

News

Receive news related to IOVANCE BIOTHERAPEUTICS, INC.

Track Activities on IOVA